medications are available
and affordable to all
Because eliminating shortages and high prices is in the best interest of patients.
Leading a movement for patients, not profits
Quality generic medicines.
Game-changing affordable insulin.
Medication prices based on the cost of manufacture – not shareholder return.
Funding Civica projects in healthcare markets that are not working for patients, such as affordable insulin.
Created by hospitals… for hospitals
Established by U.S. member hospitals and philanthropic organizations, Civica is focused on ending drug shortages.
Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages.
Hospital pharmacists and physicians help prioritize what medications we provide. By signing long-term purchase and supply contracts that add stability to the market, we help stabilize the market. Civica targets 6 months of extra inventory, enabling us to buffer any supply shortage in the market.
Currently providing nearly 80 medications to over 1,400 U.S. hospitals, Civica will have an even deeper impact in reducing drug shortages as more members join.
Our new state-of-the-art manufacturing facility in Virginia will produce quality generic sterile injectable medications for hospitals and affordable biosimilar insulins for consumers.
Lowering the cost of select high-priced generic drugs
Dedicated to making quality outpatient generic medicines affordable and available, CivicaScript builds on the mission of sister company Civica, Inc. to reach consumers directly.
CivicaScript works with trusted manufacturing partners to develop quality generic medicines.
Partnerships with like-minded payors, pharmacy benefit managers and pharmacies enable significant cost savings to be passed along to their customers.
Innovating through a nonprofit funding model
A 501(c)(3) organization that fosters philanthropic support for Civica’s work to manufacture and distribute affordable medications.
The Foundation’s first commitment is to support Civica’s efforts to bring affordable insulin to all Americans. Leaders from nearly every corner of the diabetes ecosystem are partners in this initiative.
- Arkansas BCBS
- Arnold Ventures
- BCBS Association
- BCBS of Vermont
- Blue Cross of Idaho
- Blue Shield of California
- CareFirst BCBS
- Ellen and Eason Leake
- Excellus BCBS (NY)
- Florida Blue Foundation
- Gary and Mary West Foundation
- Goldman Sachs (GS) Gives
- Hawaii BCBS
- Highmark Inc.
- Horizon/NJ
- Immaculata High School
- Independence Blue Cross
- Intermountain Health
- JDRF
- Kaiser Permanente
- Peterson Center on Healthcare Providence
- State of California
- The Caring Foundation/BCBS of Alabama
- The Glen E. Tullman Fund
- The Leona M. & Harry B. Helmsley Charitable Trust
- The Lisa & Steve Altman Family Foundation
- Transcarent
- Trinity Health
- VanTrieste Family Fund
Together, we will make affordable insulin a reality.
